Plasma NFL predicting fatigue conversion in early Parkinson’s disease
Objective: we explore if there was an association between plasma NFL and different fatigue subtypes and whether baseline plasma NFL level can predict fatigue subtype…Gender Disparities in Depressive Symptoms among Hispanic Parkinson’s Disease Patients: A Cross-Sectional Study
Objective: Investigate gender-specific disparities in depressive symptoms among Hispanic Parkinson's disease (PD) patients using Center for Epidemiologic Studies Depression Scale (CES-D) scores. Background: PD not…Rural Tanzania’s Wide “PD Gap” Through the Decades
Objective: To provide an impression of the Parkinson’s disease (PD) diagnosis and treatment gap across 4 decades in rural Sub Saharan Africa (SSA). Background: PD…Association between Dipeptidyl Peptidase-4 Inhibitor Usage and Mortality in Parkinson’s Disease: a nation-wide study
Objective: To investigate whether usage of dipeptidyl peptidase IV inhibitors (DPP4i) is associated decreased mortality in Parkinson’s disease (PD). Background: Type 2 diabetes mellitus (T2DM)…Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology correlates with self-perception of health in patients with IPDWD. Background: Parkinson's disease is a neurodegenerative pathology characterized by motor…Role of Wearable Devices in a Physical Activity Coaching Program for People with Parkinson Disease
Objective: Use a mixed-methods approach to evaluate wear-time and physical activity (PA) levels, and explore individual perspectives and feature preferences of people with Parkinson Disease…ProACT Study Protocol: a Randomized, Wait-list Controlled, Pragmatic Study on Parkinson’s Disease Multimodal Complex Treatment
Objective: To describe (1) the real-world effectiveness of the multidisciplinary inpatient rehabilitation (MIR) ‘Parkinson’s Disease Multimodal Complex Treatment’ (PD-MCT) in people with PD (PwP) compared…Parkinson’s Disease Clinical Subtypes Differ in Health-Related QOL
Objective: To determine whether clinical subtypes of Parkinson disease (PD) differ in health-related quality of life (QOL). Background: Health-related QOL varies for individuals with PD.…Health Care Utilization at the End-Of-Life in Parkinson´s Disease
Objective: This study aims to increase knowledge concerning end of life health care utilization among an urban-dwelling Parkinson's disease (PD) cohort. More specifically we investigated frequency…Nocturnal Use of Add-On Medications for Parkinson’s Disease: Post Hoc Analysis of the COSMOS Study
Objective: To assess nighttime use of add-on medications for Parkinson’s disease (PD) in a post hoc analysis of the COSMOS (COmedication Study assessing Mono- and…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 338
- Next Page »